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Abstract
Purpose We report on an unusual familial outbreak of a
coxsackie virus infection in Switzerland in which five
family members were affected. Most of the patients pre-
sented with signs of meningitis, and four were hospitalized.
Methods In three individuals, the virus was detected in
the cerebrospinal fluid, pharynx, and stool, respectively.
The genome was sequenced in specimens of two patients.
Results The nucleotide sequences of both virus strains
were identical. Blast search revealed that the first half of
the sequence was 88 % homologous to Enterovirus 75
(EV-75), 87 % with Echovirus 11 (E-11), and 84 %
homologous to Coxsackie virus A9 (CV-A9). The second
half of the sequence was 77 % homologous to EV-75,
75 % to E-11, and 91 % to CV-A9.
Conclusion We propose that the isolated virus strain is a
recombinant strain with a 50 untranslated region and with
the start of the VP4 sequence originating from E-11/EV-75
and the rest of the genome originating from CV-A9.
Interestingly, this novel virus strain showed an exceptional
virulence and rapid spread. Two weeks after the initial
outbreak in this family, a similar outbreak was observed in
a second geographic area roughly 100 km distant to the
primary identification site, and another 2 months later this
virus strain was found to circulate in the western part of
Switzerland some 250 km distant to the primary locus.
These findings suggest that genetic recombination has
resulted in a novel enterovirus with features of high viru-
lence, contagiosity, and spreading.
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Introduction
Human enteroviruses are taxonomically split into four
different species (A–D), with the different coxsackie
viruses being classified into Enterovirus A, B, and C spe-
cies and the echoviruses into Enterovirus B species [1, 2].
Coxsackie viruses induce a wide variety of clinical
symptoms, including aseptic meningitis, myocarditis, her-
pangina, myalgia, flu-like respiratory disease (‘‘summer
flu’’), pleurodynia, hepatitis, diarrhea, and exanthema
including hand-foot-and-mouth disease. Clinical symptoms
largely depend on the virus type as well as on patient age and
immune status. In contrast, echoviruses are typically asso-
ciated with febrile illnesses which may include rashes and
respiratory diseases. Altogether, most infections caused by
non-polio enteroviruses result only in mild febrile illness [3].
Recombination between different enteroviruses was
described for polioviruses as early as 1962 [4, 5], and it
was later also confirmed for non-polioviruses and proven to
occur frequently [2, 6–12]. The researchers conducting
these studies speculated that recombination contributes to
the evolution of new genetic virus lineages with novel
properties.
We report here an unusual family outbreak of a
recombinant Coxsackie A9 virus with high incidence of
acute meningitis and rapid spread within Switzerland.
Materials and methods
Patients
We report on a family of five members living next to Lake
Constance in eastern Switzerland. The father, mother, and
two children were living together in one household. An uncle
from outside frequently took care of the children. All five
family members fell sick and were suffering from a febrile
infection with strong headache. The first to fall ill was the
younger of the two children, a 16-month-old boy, followed
by his uncle, father, brother and mother. All individuals
except for the mother were hospitalized (Table 1).
Diagnostic methods
Virus isolation and immunofluorescence
Virus isolation attempts succeeded in two specimens of
stool on Rita cells, but failed on Vero, A549, MRC5, and
Caco 2 cells as well as in the throat swap specimen. The
isolated cytopathogenic virus was subtyped as a Coxsackie
A9 virus by using a set of anti-enterovirus monoclonal
antibodies (Chemicon, Temecula, CA).
RNA extraction, reverse transcription-PCR and
real-time PCR
RNA was extracted from clinical specimens, such as
cerebrospinal fluid (CSF), swabs, and stool by using the
Table 1 Clinical features and microbiological findings of the five affected family members
Case Relationship Age Main symptoms (onset) Microbiological investigations
Material Method Result
1 Younger boy 16 months Fever, cough, coryza (day 0) Smear: pharynx Cell culture Enterovirus negative
Immunofluorescence Enterovirus antigen negative
Stool Cell culture Enterovirus negative
Immunofluorescence Enterovirus antigen negative
2 Uncle
(paternal
side)
31 years Headache, fever,
vomiting (day 0)
CSF RT-PCR Enterovirus RNA positive
Smear: pharynx RT-PCR Enterovirus RNA positive
Cell culture Enterovirus negative
3 Father 43 years Headache, fatigue,
vomiting (day 4)
CSF RT-PCR Enterovirus RNA positive
Stool RT-PCR Enterovirus RNA positive
Cell culture Enterovirus positive
4 Older boy 3 years Fever, headache, coryza, rash,
abdominal pain (day 6)
CSF RT-PCR Enterovirus RNA positive
Smear: pharynx Immunofluorescence Enterovirus antigen negative
Cell culture Enterovirus negative
Stool Immunofluorescence Enterovirus Antigen negative
Cell culture Enterovirus positive
5 Mother 36 years Headache, fever, nausea (day 10) Not done Not available Not available
CSF cerebrospinal fluid, RT reverse transcriptase
232 R. Butsch et al.
123
NucliSens easyMAGTM nucleic acid extraction system and
reagents (Biome´rieux, Marcy-l’Etoile, France). Reverse
transcribed (RT) RNA (Superscript II; Invitrogen, Carlsbad
CA) was then assayed with the Entero/Ge/08 real-time
PCR assay using oligonucleotide sequences and amplifi-
cation protocol previously described [13]. For genotyping,
cDNA was amplified with forward (50-CCC CTG AAT
GCG GCT AAT-30) and reverse primers (ATCHGGHA
RYTTCCAMCACCA). All PCR products were purified by
passage through Microcon spin columns (Millipore, Bille-
rica MA) and sequenced in the ABI Prism 3130XL DNA
Sequencer (Applied Biosystems, Foster City, CA). Chro-
matograms were imported for proofreading with the
Geneious Pro software (Biomatters, Queensland, New
Zealand), and the sequences are available at Genbank
(accession numbers JQ037833–JQ037835).
Phylogenetic analysis
Trees were built with the PhyML software program using
the generalized time-reversible model and optimized tree
topology and branch lengths [14] (see Fig. 1). The transi-
tion/transversion ratio and relative substitution rate cate-
gories were set to 4 and 8, respectively. The gamma shape
parameter alpha and proportions of invariant sites were
estimated from the data.
Results
Case descriptions
The clinical features of the five affected family members
and the timely relationship are summarized in Table 1.
Case 1
The first family member to fall ill was the 16-month-old
son who developed fever up to 39.3 C with coryza and
cough. His stool was loose but diarrhea was not present. He
was hospitalized as a precaution together with his relatives
10 days after the onset of clinical symptoms. At initial
exam, he had partly recovered, was in good general con-
dition, afebrile, with a heart rate of 125 beats per minute
(bpm) and a respiratory rate of 26 breaths per minute.
Apart from rhinitis, no other clinical signs of infection
were found. No signs of meningitis were present. Labora-
tory analysis showed a leukocytosis of 22,100 cells/ll
(66 % mononuclear) and C-reactive protein (CRP) of
4 mg/l. Cough and rhinitis vanished within another 2 days,
and he was discharged from the hospital. The search for
enterovirus by cell culture and RT-PCR in stool and pha-
ryngeal secretions was negative.
Case 2
The 31-year-old uncle fell sick at about the same time as
case 1 with rhinitis, sore throat, cough and fever up to
38.8 C. One week later he developed headache and
vomiting. On admission 1 day later, his temperature was
36.5 C, blood pressure was 140/80 mmHg, and his heart
rate was 76 bpm. General and neurological examinations
were normal without signs of meningitis. Leukocytes were
at 11,900/ll and CRP at 12 mg/l. Analysis of the CSF
showed that he had 12 cells/ll (99 % mononuclear cells).
Cultures from CSF and blood as well as a PCR assay for
herpes simplex virus Type 1 and 2 were negative. RT-PCR
analysis of the CSF and pharyngeal secretions revealed the
presence of enterovirus. The patient recovered slowly and
was able to leave the hospital after 3 days.
Case 3
Of all family members, the 43-year-old father suffered the
most from infection, resulting in a high level of disability.
The symptoms had evolved over a period of several days,
beginning 4 days later than those of case 1. Another 4 days
later he was hospitalized, 2 days before his relatives,
because of severe persistent headache with nausea and
vomiting. Photophobia and phonophobia had also devel-
oped. Neurologic examination, laboratory findings, and
magnetic resonance imaging (MRI) of the brain were
normal. His temperature was 36.6 C, blood pressure was
136/80 mmHg, and his heart rate was 80 bpm. Clinical
examinations as well as routine laboratory analyses were
normal. Analysis of the CSF revealed 218 cells/ll, with
100 % mononuclear cells. The presence of enterovirus was
demonstrated by RT-PCR in the CSF and stool, as well as
by cell culture in stool. Other cultures of CSF and blood
remained negative, as well as a PCR assay for herpes
simplex virus type 1 and 2 and serologic examinations for
Epstein–Barr virus, cytomegalovirus, Borrelia burgdorferi,
and tick-borne encephalitis (FSME). This patient was dis-
charged from hospital after 5 days, but continued to suffer
from residual pain and fatigue for a further 2 months.
Case 4
The second son, a 3-year-old toddler, became ill 6 days
after case 1. He suffered from headache, cough, abdominal
pain, an itching rash, and fever of 39 C. He was hospi-
talized together with the brother and the uncle another
3 days later. Rhinitis, a slight redness of the pharynx and
the left drumhead, as well as pronounced borborygmi were
noted. Blood analysis revealed 12,900 leukocytes/ll, and
the CRP was \1 mg/l. The cell count in the CSF was
distinctly elevated with 490 cells/ll (95 % were
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mononuclear cells). Enterovirus was determined by RT-
PCR in the CSF and by cell culture in the stool, whereas
bacterial cultures remained negative. He recovered rapidly
and could leave the hospital after a short time.
Case 5
Ten days after case 1, the 36-year-old children’s mother
developed a similar condition. For 2 weeks she suffered
from headache, which initially was strong and associated
with fever and nausea. She was not admitted to hospital
and no further investigations were conducted.
Results of molecular typing
Enterovirus strains sequenced from the CSF and swab
samples from patients revealed no difference along the 618
bases analyzed [from nucleotide (nt) 518 to 1,135] with
reference to human Coxsackie virus A9 (CV-A9) strain
(Genbank accession D00627.1). Blast analysis (http://blast.
ncbi.nlm.nih.gov/Blast.cgi) revealed that the first half of
the sequence (from nt 518 to 833, with reference to
D00627) was 88 % homologous to Enterovirus 75 (EV-75)
(AY556070), 87 % homologous with Echovirus 11 (E-11)
(AJ577594) strain, and 84 % homologous to CV-A9; in
contrast, the second half of the sequence (from nt 833 to
1,135) was 77 % homologous to EV-75, 75 % homologous
to E-11, and 91 % homologous to CV-A9. These results
were further confirmed by a comparison of the phyloge-
netic trees obtained with fragments nt 518–833 and nt
834–1,135 from the sequences of the clinical strains with
the CV-A9, EV-75, and E-11 strains (Fig. 1a, b). There-
fore, we conclude that this strain is a recombinant strain
with a 50 untranslated region (UTR) and around 89 nucle-
otides of VP4 sequence originating from E-11/EV-75 and
the rest of the genome originating from CV-A9 virus.
Discussion
Epidemic clusters of aseptic meningitis are caused mostly
by Coxsackie B viruses and echoviruses. Coxsackie A9
viruses have also been associated with large outbreaks of
aseptic meningitis [15–20]. This latter virus strain was
found to be the causative agent in our family. Fever, severe
headache, nausea, vomiting, and redness of throat have
been reported in similar outbreaks and also observed in
four of our family members [18, 19].
Transmission occurs efficiently by the fecal–oral route
[3]. As such, the most likely route of transmission was
from the 16-month-old child to his father and uncle, who
both were regularly changing the infant’s diapers. The
other child was probably infected through direct contact
with his index brother, whereas the mother was infected
Fig. 1 Phylogenetic analysis of
the enterovirus recombinant
strains. Phylogenetic trees were
computed using sequences
(a) cut before the putative
recombination point
[corresponding to nucleotides
(nt) 518–833 of the CVA9
genome; GenBank D00627] or
(b) after recombination
(corresponding to nt 824–1,135
of the CVA9 genome). Two
samples were collected from
patient 2, and one sample was
collected from patient 4. As
references, corresponding
sequences from representatives
of Coxsackievirus A9 (CVA9),
Echovirus 11 (E11) and
Enterovirus 75 (EV75) were
included. Coxsackievirus B1
(CVB1) was used as an
outgroup. The NCBI accession
numbers are shown in the tree
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secondarily by either her children or her husband. How-
ever, this chain of transmission cannot be proven due to
lack of a positive RT-PCR results from both the youngest
boy and the mother.
Recombination among different enterovirus strains
co-circulating in the population is a well-known phenom-
enon [2, 21, 22]. Results from previous investigations on
the molecular epidemiology of Coxsackie virus A9 suggest
recombination predominantly in the nonstructural protein
genome region [2], with hot spots of recombination having
been mapped in enteroviruses in the 50UTR and nonstruc-
tural genes [23].
The virus identified in this study is a recombinant
Coxsackie virus A9 strain that acquired the 50UTR and part
of the VP4 coding sequence from an echovirus (likely E-11
or EV-75). To our knowledge, recombination breakpoints
in capsid-encoding regions have not been described in the
literature to date. The minor recombination in the capsid
VP4 coding sequence did not change the antigenic prop-
erties of the maternal Coxsackie virus since the recombi-
nant reacted with a monoclonal anti-Coxsackie A9
antibody but failed to react with a monoclonal anti-ECHO
11 antibody. The 50UTR contains important secondary
structures involved in the regulation of both replication and
translation [24]. Therefore, acquisition of a new 50UTR
may improve virus fitness and in the cases reported in this
study, virulence and contagiosity.
The rapid spread of this viral strain across Switzerland
supports this hypothesis and the interpretation of genetic
recombination as a driving force in the evolution of novel
enterovirus lineages. A similar outbreak was observed
2 weeks later in a second geographic area roughly 100 km
distant to first one, with the same virus being confirmed by
phenotypical criteria. Another 2 months later this virus was
shown to circulate in the western part of Switzerland some
250 km distant, presenting 97.9 % identity at the nucleo-
tide level and 100 % identity at the amino acid level
(C. Tapparel, personal communication).
Finally this recombination occurred between two
members of the same human enterovirus B (HEV-B) spe-
cies. To our knowledge, in vivo interspecies recombination
has not been previously described.
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